USFDA gave 8-9 observations on the drug major’s Goa plant after inspection that ended on March 11, as per media reports.
Lupin cracked 5% to Rs.1,776.25 on BSE. According to media reports, USFDA gave 8-9 observations on the drug major’s Goa plant after inspection that ended on March 11.
The scrip opened at Rs. 1800 and has touched a high and low of Rs. 1800 and Rs. 1736.5 respectively. So far 1904899(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 84186.87 crore.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2127 on 06-Oct-2015 and a 52 week low of Rs. 1589.4 on 14-May-2015. Last one week high and low of the scrip stood at Rs. 1874.3 and Rs. 1762 respectively.
The promoters holding in the company stood at 46.53 % while Institutions and Non-Institutions held 43.56 % and 9.92 % respectively.
The stock is currently trading below its 200 DMA.
Lupin cracked 5% to Rs.1,776.25 on BSE. According to media reports, USFDA gave 8-9 observations on the drug major’s Goa plant after inspection that ended on March 11.The scrip opened at Rs. 1800 and has touched a high and low of Rs. 1800 and Rs. 1736.5 respectively. So far 1904899(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 84186.87 crore.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2127 on 06-Oct-2015 and a 52 week low of Rs. 1589.4 on 14-May-2015. Last one week high and low of the scrip stood at Rs. 1874.3 and Rs. 1762 respectively.
The promoters holding in the company stood at 46.53 % while Institutions and Non-Institutions held 43.56 % and 9.92 % respectively.
The stock is currently trading below its 200 DMA.
No comments:
Post a Comment